Cargando…
Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis
Interleukin (IL)-8 plays a vital role in regulating inflammation and breast cancer formation by activating CXCR1/2. We previously designed an antagonist peptide, (RF16), to inhibits the activation of downstream signaling pathways by competing with IL-8 in binding to CXCR1/2, thereby inhibiting IL-8-...
Autores principales: | Chang, Chun-Ming, Chang, Chun-Chun, Lam, Ho Yin Pekkle, Peng, Shih-Yi, Lai, Yi-Hsuan, Hsiang, Bi-Da, Liao, Yu-Yi, Hsu, Hao-Jen, Jiang, Shinn-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531501/ https://www.ncbi.nlm.nih.gov/pubmed/37762330 http://dx.doi.org/10.3390/ijms241814029 |
Ejemplares similares
-
Flavopereirine Inhibits Autophagy via the AKT/p38 MAPK Signaling Pathway in MDA-MB-231 Cells
por: Chen, Ming-Shan, et al.
Publicado: (2020) -
A novel UTMD system facilitating nucleic acid delivery into MDA-MB-231 cells
por: Zhang, Hui, et al.
Publicado: (2020) -
Effects of FSTL1 on cell proliferation in breast cancer cell line MDA-MB-231 and its brain metastatic variant MDA-MB-231-BR
por: An, Jiaqiang, et al.
Publicado: (2017) -
Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells
por: Li, Liyuan, et al.
Publicado: (2010) -
Potential Effects of Chrysin on MDA-MB-231 Cells
por: Hong, Teh Ban, et al.
Publicado: (2010)